The American Headache Society (AHS) is partnering with Pfizer to launch the Headache and Migraine Competitive Grant Program, which will fund projects to address critical gaps in headache medicine.
The program, made possible by Pfizer’s support, focuses on improving the quality of care for people who are affected by migraines and other headache disorders.
The AHS is now calling for proposals as part of a quality improvement initiative in headache medicine. Proposals of any scope,